CSRXP: SENATE JUDICIARY COMMITTEE CRACKS DOWN ON BIG PHARMA PATENT ABUSE

07-29-2021 Press Release

Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’ Anti-Competitive Tactics Adds to Momentum on Capitol Hill to Lower Rx Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today reacting to the unanimous, bipartisan passage of two bills in the U.S. Senate Committee on the Judiciary that would […]

CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE

07-9-2021 Press Release

Campaign Looks Forward to Working with Administration and Congress to Crack Down on Anti-Competitive Practices and Lower Rx Price Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to executive order and comments from President Biden encouraging increased federal action to lower drug prices and hold Big Pharma […]

CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE

07-8-2021 Press Release

U.S. House Oversight & Reform Committee Report Shines Light on Branded Drugmakers’ Profiteering Practices, Debunks Innovation Rhetoric Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to a new report from the U.S. House Committee on Oversight and Reform examining financial data from 14 of the largest drug […]

CSRxP: Big Pharma Flaunts Disregard for Rx Affordability With Third Major Round of Pandemic Price Hikes

07-1-2021 Press Release

Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday in response to a fresh round of price hikes from Big Pharma as the nation tries to recover from the COVID-19 pandemic. Big Pharma increased prices on 32 brand […]

ICYMI: BIG PHARMA USES INFLUENCE OVER PATIENT GROUPS & ASTROTURF TACTICS TO UNDERMINE RX SOLUTIONS

06-30-2021 Press Release

New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you missed it, Patients for Affordable Drugs (P4AD) released a new report Tuesday examining the financial levers and tactics used by Big Pharma to influence patient advocacy groups and a network of AstroTurf organizations to undermine support for solutions to lower drug prices […]

CSRXP APPLAUDS U.S. HOUSE PROBE INTO BIOGEN PRICING OF ADUHELM

06-25-2021 Press Release

Pallone and Maloney Announce Joint Investigation into Massive Price Tag on Unproven Alzheimer’s Treatment as Outrage Builds Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the announcement of a joint investigation into the pricing of unproven Biogen Alzheimer’s treatment Aduhelm by Representative Frank Pallone (D-NJ), Chairman of the U.S. House […]

CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM

06-11-2021 Press Release

Troubling for Public Health Institution to Depart from Established Norms to Support Drug of Questionable Efficacy with Unjustifiable Price Tag Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reflecting on the recent U.S. Food and Drug Administration (FDA) approval of Alzheimer’s treatment aducanumab, brand name Aduhelm. “Policymakers must carefully and […]

CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW

06-1-2021 Press Release

Campaign Calls for Promises Made to the American People to Lower Prescription Drug Prices to Become Promises Kept Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) launched new television and digital advertising Tuesday encouraging policymakers to hold brand name drug companies accountable. The ad blitz, part of CSRxP’s Promises Made campaign, will target […]

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET

05-28-2021 Press Release

Time for the Administration and Congress to Convert Promises Made Into Promises Kept Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement Friday on the release of President Biden’s Fiscal Year 2022 budget. “CSRxP commends President Biden for renewing his commitment to lowering prescription drug prices in his administration’s first budget,” said […]

CSRXP APPLAUDS PRESIDENT BIDEN’S CALL FOR BIPARTISAN SOLUTIONS TO LOWER DRUG PRICES

04-29-2021 Press Release

Administration and Congress Must Work Together To Pass Solutions to Hold Big Pharma Accountable and Deliver Relief for American People Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday in reaction to President Biden’s comments calling for Congress to pass solutions to lower prescription drug costs this year. “We applaud the […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.